Ex-Cedilla CEO Glucksmann explores ‘new frontier’ at Sensorium; R&D chief out at Merck women’s health spinoff Organon

Alexandra Glucksmann

Alexandra Glucksmann is always looking for “the next frontier” in medicine. After spending most of her career in genetic diseases, rare diseases and oncology, her next pursuit is in mental health.

The longtime biopharma executive is the next CEO at Sensorium Therapeutics, a…
Click here to view original post